SUBSEQUENT EVENTS	9 Months Ended
Sep. 30, 2021
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	18. SUBSEQUENT EVENTS On October 8, 2021, the Board of Managers of SeD Maryland Development LLC (the 83.55% owned subsidiary of the Company which owns the Company’s Ballenger Project) authorized the payment of distributions to its members in the amount of $7,000,000. Accordingly, the minority member of SeD Maryland Development LLC received a distribution in the amount of $1,151,500, with the remainder being distributed to a subsidiary of the Company, which is eliminated upon consolidation. On October 13, 2021, BMI Capital Partners International Limited (“BMI”), a subsidiary of our majority-owned subsidiary Alset International Limited, entered into a loan agreement to loan $3,000,000 to Liquid Value Asset Management Limited, a Hong Kong limited company (“LVAM HK”). 60% of LVAM HK is owned by a subsidiary of DSS. Our Chairman and CEO, Chan Heng Fai, along with a member of the Company’s Board of Directors, Wu Wai Leung William, each serve on both our Board and the Board of DSS. Chan Heng Fai is also a significant shareholder of DSS. Our Co-CEO, Chan Tung Moe, also serves on the Board of DSS. LVAM HK will engage in proprietary algorithmic trading. On October 29, 2021, the Company’s subsidiary, Alset International Limited, entered into a Subscription Agreement with American Medical REIT Inc. (“AMRE”) to purchase a convertible promissory note (the “AI Note”) in the principal amount of $8,350,000. The AI Note is due 25 months from the AI Note’s date. Interest on the outstanding balance of the AI Note is 8% per annum. Additionally, at any time on or before maturity date, the unpaid principal and interest balance of the AI Note can be converted in whole or in part, into fully-paid and non-assessable shares of AMRE’s Common Stock at variable conversion rate of $10 per share. On October 29, 2021, another of the Company’s subsidiaries, LiquidValue Asset Management Pte. Ltd. (“LVAM”), entered into a Subscription Agreement with AMRE. On March 2, 2020 AMRE sold LVAM a promissory note (the “March 2020 Note”) for a purchase price of $200,000. Pursuant to the terms of March 2020 Note, AMRE granted LVAM an option (the “Loan Option”) to lend AMRE up to an additional $200,000 and with a grant of warrants that shall be exercisable for four years and are exercisable into shares of AMRE’s common stock, at the exercise price of $5 per share. On October 29, 2021 LVAM exercised the Loan Option and was issued a promissory note (the “LVAM Note”) in the principal amount of $200,000, pursuant to the same terms as the March 2020 Note. The LVAM Note is due in three years and carries the interest rate of 8% per annum.

SUBSEQUENT EVENTS

9 Months Ended

Sep. 30, 2021

18. SUBSEQUENT EVENTS

On October 8, 2021, the Board of Managers of SeD Maryland Development LLC (the 83.55% owned subsidiary of the Company which owns the Company’s Ballenger Project) authorized the payment of distributions to its members in the amount of $7,000,000. Accordingly, the minority member of SeD Maryland Development LLC received a distribution in the amount of $1,151,500, with the remainder being distributed to a subsidiary of the Company, which is eliminated upon consolidation.

On October 13, 2021, BMI Capital Partners International Limited (“BMI”), a subsidiary of our majority-owned subsidiary Alset International Limited, entered into a loan agreement to loan $3,000,000 to Liquid Value Asset Management Limited, a Hong Kong limited company (“LVAM HK”). 60% of LVAM HK is owned by a subsidiary of DSS. Our Chairman and CEO, Chan Heng Fai, along with a member of the Company’s Board of Directors, Wu Wai Leung William, each serve on both our Board and the Board of DSS. Chan Heng Fai is also a significant shareholder of DSS. Our Co-CEO, Chan Tung Moe, also serves on the Board of DSS. LVAM HK will engage in proprietary algorithmic trading.

On October 29, 2021, the Company’s subsidiary, Alset International Limited, entered into a Subscription Agreement with American Medical REIT Inc. (“AMRE”) to purchase a convertible promissory note (the “AI Note”) in the principal amount of $8,350,000. The AI Note is due 25 months from the AI Note’s date. Interest on the outstanding balance of the AI Note is 8% per annum. Additionally, at any time on or before maturity date, the unpaid principal and interest balance of the AI Note can be converted in whole or in part, into fully-paid and non-assessable shares of AMRE’s Common Stock at variable conversion rate of $10 per share.

On October 29, 2021, another of the Company’s subsidiaries, LiquidValue Asset Management Pte. Ltd. (“LVAM”), entered into a Subscription Agreement with AMRE. On March 2, 2020 AMRE sold LVAM a promissory note (the “March 2020 Note”) for a purchase price of $200,000. Pursuant to the terms of March 2020 Note, AMRE granted LVAM an option (the “Loan Option”) to lend AMRE up to an additional $200,000 and with a grant of warrants that shall be exercisable for four years and are exercisable into shares of AMRE’s common stock, at the exercise price of $5 per share. On October 29, 2021 LVAM exercised the Loan Option and was issued a promissory note (the “LVAM Note”) in the principal amount of $200,000, pursuant to the same terms as the March 2020 Note. The LVAM Note is due in three years and carries the interest rate of 8% per annum.